Team:Duke

From 2012.igem.org

(Difference between revisions)
(Executive Summary)
 
(27 intermediate revisions not shown)
Line 1: Line 1:
-
<!-- *** What falls between these lines is the Alert Box!  You can remove it from your pages once you have read and understood the alert *** -->
 
-
 
<html>
<html>
-
<div id="box" style="width: 700px; margin-left: 137px; padding: 5px; border: 3px solid #000; background-color: #fe2b33;">
 
-
<div id="template" style="text-align: center; font-weight: bold; font-size: large; color: #f6f6f6; padding: 5px;">
 
-
This is a template page. READ THESE INSTRUCTIONS.
 
-
</div>
 
-
<div id="instructions" style="text-align: center; font-weight: normal; font-size: small; color: #f6f6f6; padding: 5px;">
 
-
You are provided with this team page template with which to start the iGEM season.  You may choose to personalize it to fit your team but keep the same "look." Or you may choose to take your team wiki to a different level and design your own wiki.  You can find some examples <a href="https://2009.igem.org/Help:Template/Examples">HERE</a>.
 
-
</div>
 
-
<div id="warning" style="text-align: center; font-weight: bold; font-size: small; color: #f6f6f6; padding: 5px;">
 
-
You <strong>MUST</strong> have all of the pages listed in the menu below with the names specified. PLEASE keep all of your pages within your teams namespace. 
 
-
</div>
 
-
</div>
 
-
</html>
 
-
<!-- *** End of the alert box *** -->
 
-
blabla
+
<style>
 +
body {
-
{|align="justify"
+
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
+
-
|[[Image:Duke_logo.png|200px|right|frame]]
+
-
|-
+
-
|
+
-
''Tell us more about your project.  Give us background.  Use this as the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
+
-
|[[Image:Duke_team.png|right|frame|Your team picture]]
+
-
|-
+
-
|
+
-
|align="center"|[[Team:Duke | Team Duke]]
+
-
|}
+
-
<!--- The Mission, Experiments --->
 
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
}
-
!align="center"|[[Team:Duke|Home]]
+
 
-
!align="center"|[[Team:Duke/Team|Team]]
+
 
-
!align="center"|[https://igem.org/Team.cgi?year=2012&team_name=Duke Official Team Profile]
+
/* Sidebar */
-
!align="center"|[[Team:Duke/Project|Project]]
+
 
-
!align="center"|[[Team:Duke/Parts|Parts Submitted to the Registry]]
+
#sidebar {
-
!align="center"|[[Team:Duke/Modeling|Modeling]]
+
float: right;
-
!align="center"|[[Team:Duke/Notebook|Notebook]]
+
width: 253px;
-
!align="center"|[[Team:Duke/Safety|Safety]]
+
}
-
!align="center"|[[Team:Duke/Attributions|Attributions]]
+
 
-
|}
+
#sidebar ul {
 +
margin: 0;
 +
padding: 0;
 +
list-style: none;
 +
line-height: normal;
 +
}
 +
 
 +
#sidebar li {
 +
margin-bottom: 40px;
 +
padding: 0 15px 0 20px;
 +
}
 +
 
 +
#sidebar li ul {
 +
}
 +
 
 +
#sidebar li li {
 +
margin: 0;
 +
padding: 5px 0;
 +
border-bottom: 1px solid #E5E5E5;
 +
}
 +
 
 +
#sidebar li h2 {
 +
margin-bottom: 15px;
 +
font-size: 18px;
 +
}
 +
 
 +
 
 +
/* Menu */
 +
 
 +
#menu {
 +
width: 960px;
 +
height: 62px;
 +
margin: 0;
 +
border-top: 0;
 +
    border-right: 0;
 +
    border-left: 0;
 +
    padding: 0;
 +
background: #252E3A url(http://i.imgur.com/bDFvK.jpg) no-repeat;
 +
}
 +
 
 +
#menu ul {
 +
margin: 0;
 +
padding: 21px 0 0 30px;
 +
list-style: none;
 +
line-height: normal;
 +
}
 +
 
 +
#menu li {
 +
float: left;
 +
padding: 0 20px 0 22px;
 +
background: url(http://i.imgur.com/zJfPx.gif) no-repeat left center;
 +
}
 +
 
 +
#menu li.first {
 +
background: none;
 +
}
 +
 
 +
#menu a {
 +
text-decoration: none;
 +
font-size: 14px;
 +
font-weight: bold;
 +
color: #FFFFFF;
 +
}
 +
 
 +
body {
 +
  background: white;
 +
  color: black;
 +
  margin: 0;
 +
  border: 0;
 +
  padding: 0;
 +
  background: url("http://www.wallpapersforvista.com/images/wallpapers/BlueKetamine1186424340-1600x1200.jpg");
 +
}
 +
</style>
 +
 
 +
<body>
 +
<div id="banner"><img src="http://i.imgur.com/kBtYW.png" alt="" /></div>
 +
 
 +
 
 +
<div id="menu">
 +
<ul>
 +
<li class="first"><a href="https://2012.igem.org/Team:Duke" accesskey="1"  
 +
title="">Home</a></li>
 +
<li><a href="https://2012.igem.org/Team:Duke/Team" accesskey="2"
 +
title="">Meet the Team</a></li>
 +
<li><a href="https://2012.igem.org/Team:Duke/Project" accesskey="3"
 +
title="">Project Description</a></li>
 +
<li><a href="https://2012.igem.org/Team:Duke/Safety" accesskey="4"
 +
title="">Safety</a></li>
 +
<li><a href="https://2012.igem.org/Team:Duke/Notebook" accesskey="5"
 +
title="">Lab Notebook</a></li>
 +
<li><a href="https://2012.igem.org/Team:Duke/Sponsors" accesskey="5"
 +
title="">Sponsors</a></li>
 +
                <li><a href="https://2012.igem.org/Team:Duke/Human Practices" accesskey="6"
 +
title="">Human Practices</a></li>
 +
</ul>
 +
 +
</div>
 +
 
 +
<!-- start page -->
 +
<div id="page">
 +
<!-- start content -->
 +
 +
<h2 class="title"><a href="#">Welcome to the Duke iGEM Wiki!</a></h2>
 +
<!-- end content -->
 +
<!-- start sidebar -->
 +
<div id="sidebar">
 +
<ul>
 +
 +
<li>
 +
<h2>Duke iGEM 2012</h2>
 +
<p></p>
 +
</li>
 +
 
 +
 
 +
<li>
 +
<h2>Useful Links</h2>
 +
<ul>
 +
<li><a href="http://www.genome.duke.edu/">Duke University IGSP</a></li>
 +
<li><a href="http://www.bowmanbrockman.org/ncssm/">Bowman Brockman</a></li>
 +
<li><a href="http://www.geneoracle.com/">Gene Oracle</a></li>
 +
<li><a href="http://www.synberc.org/">SynBERC</a></li>
 +
<li><a href="http://pubs.acs.org/journal/asbcd6">ACS Synethetic Biology</a></li>
 +
 +
</ul>
 +
</li>
 +
</ul>
 +
 +
 +
</div>
 +
</div>
 +
<!-- end page -->
 +
 
 +
</body>
 +
</html>
 +
 
 +
===Executive Summary===
 +
One of the most promising fields of medical genetic research is gene therapy, which seeks to deliver genes to patients to treat medical conditions. Identifying genes that can be used as therapeutics is critical for the progression of gene therapy to clinical trials. However, current methods for identifying gene therapeutic targets are slow and expensive: the cost of analyzing a gene is $2146.75 and can take three weeks before analysis. The goal of our work was to develop a toolkit for researchers to use for more rapid and cost-efficient identification of gene therapeutic targets. In yeast, a model of human genes, we used an emerging topic known as optogenetics to create a light switch for gene activation: we can activate specific genes in our samples with the addition of blue light. After verifying the functionality of our system, we compiled our utilities into a physical toolkit, which contains custom yeast strains, standardized DNA parts, a computational network model, and a custom software package for rapid analysis of data. When we evaluated the performance of our toolkit, we found that we reduced waiting time during experimentation from 36 hours to 22.0 seconds (a 5900-fold speed increase), and our software reduced data analysis time from 7.5 hours to 3.45 seconds (a 7800-fold speed increase). We reduced the cost of experimental materials by 85.2% while broadening the spectrum of discovery in gene therapy. Our comprehensive toolkit streamlines identification of genetic therapeutic targets, and will speed progress toward personalized therapy of a variety of diseases.

Latest revision as of 21:13, 15 October 2012

Executive Summary

One of the most promising fields of medical genetic research is gene therapy, which seeks to deliver genes to patients to treat medical conditions. Identifying genes that can be used as therapeutics is critical for the progression of gene therapy to clinical trials. However, current methods for identifying gene therapeutic targets are slow and expensive: the cost of analyzing a gene is $2146.75 and can take three weeks before analysis. The goal of our work was to develop a toolkit for researchers to use for more rapid and cost-efficient identification of gene therapeutic targets. In yeast, a model of human genes, we used an emerging topic known as optogenetics to create a light switch for gene activation: we can activate specific genes in our samples with the addition of blue light. After verifying the functionality of our system, we compiled our utilities into a physical toolkit, which contains custom yeast strains, standardized DNA parts, a computational network model, and a custom software package for rapid analysis of data. When we evaluated the performance of our toolkit, we found that we reduced waiting time during experimentation from 36 hours to 22.0 seconds (a 5900-fold speed increase), and our software reduced data analysis time from 7.5 hours to 3.45 seconds (a 7800-fold speed increase). We reduced the cost of experimental materials by 85.2% while broadening the spectrum of discovery in gene therapy. Our comprehensive toolkit streamlines identification of genetic therapeutic targets, and will speed progress toward personalized therapy of a variety of diseases.